ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Dr Saad Highlights Results Following the ACIS Study"
Episode Synopsis
Fred Saad, MD, University of Montreal Hospital Center, highlights, "Results from ACIS, a Randomized, Placebo Controlled Double-Blind Phase 3 Study of Apalutamide and Abiraterone Acetate Plus Prednisone Versus Abiraterone in Patients with Chemo-Naive Castration-Resistant Prostate Cancer."
In God we trust